Omada Health’s Post

A study from the Lancet Medical Journal recently reported that obesity rates amongst adults has more than doubled, and quadrupled amongst children and teenagers globally. What is contributing to this worrying trend and what can we do to address it? Take a listen to this audio clip as I unpack the topic of obesity trends and weight loss strategies in more detail with CNA.

A rising trend in obesity rates has been observed globally amongst adults, teenagers and children. What is driving this trend, and what are some strategies to combat this? Tune in to Dr Kyle Tan as he spoke with CNA to dive deeper into this topic. #obesity #weightloss

#EASD ➡ Weight loss drug liraglutide is safe and effective in children under 12, study finds ◾ Children aged 6 to under 12 saw BMI fall by 7.4%, in just over a year ◾ Results offer hope that children who are living with obesity can lead healthier, more productive lives, say researchers 📰 Read the full article here: https://lnkd.in/eaZVKxPN

Did you know that obesity rates have been increasing since the 1980s? It's clear we need to change how we talk about and treat obesity. In Omada's latest whitepaper, we focus on the need to reframe obesity as a complex chronic condition that requires long-term, often lifelong treatment. This is especially true in the age of GLP-1s. Read the full whitepaper here: https://lnkd.in/gr-UrafB

Just read some fascinating research from the Pew Research Center - while over half of Americans who are familiar with GLP-1s acknowledge their benefit for weight loss in individuals with obesity or weight-related conditions, only 16% believe they'll greatly reduce overall U.S. obesity rates. It got me thinking 🤔 about the role we can play in amplifying the impact of GLP-1s to tackle obesity more broadly. At Omada Health, we don't prescribe GLP-1s, but we're committed to supporting our members in every step of their weight health journey, including weight maintenance after medication. Check out our latest white paper to see how we're helping members sustain their weight loss: https://lnkd.in/gsDZ9b6m

Obesity is a complex trait in the truest sense. The heterogeneity behind this trait at an individual level and the breadth of associations with it encourage an abandoning of simplified searches for mechanisms of obesity. In place of this, we would encourage a more fluid consideration of mechanisms associated with obesity if we are to make best use of the tools available now and in the future.

A well intentioned ad or website image may, in fact project a weight bias or fat shaming and remains an issue in the health care and fitness industry. Take the time to think over the images you select and ask yourself is this encouraging or meant to embarrass. As a former program and marketing director for Robert Marvin Bariatric surgeon, the training and material from the Obesity Action Coalition is incredibly impactful to understand that difference between bias and being helpful. Sometimes we mean well, but that’s not enough in health related marketing. Plus, as once an obese person turned Ironman, I know weight struggles all too well. Be encouraging in your visual voice. Positivity over shameful moments wins every time. #healthcaremarketing #responsiblemarketing #positivereinforcement #obesityactioncoalition #healthcareadvertising

'To mark World Obesity Day we released a comprehensive report highlighting the urgent need for a strategic, system-wide approach to obesity care. The report highlights that as healthcare professionals, policymakers, and members of the public, we all have a role to play in increasing knowledge about the causes and health impacts of obesity. It's time to find opportunities to improve the state of obesity care across the world and ensure that interventions are tailored for healthcare systems to provide optimal care for those living with obesity. To learn more about the findings and recommendations from the OPEN report, visit: https://buff.ly/3yzIpZR

Just read some fascinating research from the Pew Research Center - while over half of Americans who are familiar with GLP-1s acknowledge their benefit for weight loss in individuals with obesity or weight-related conditions, only 16% believe they'll greatly reduce overall U.S. obesity rates. It got me thinking 🤔 about the role we can play in amplifying the impact of GLP-1s to tackle obesity more broadly. At Omada Health, we don't prescribe GLP-1s, but we're committed to supporting our members in every step of their weight health journey, including weight maintenance after medication. Check out our latest white paper to see how we're helping members sustain their weight loss: https://lnkd.in/eMGbhNd8

Did you know that obesity rates have been increasing since the 1980s? It's clear we need to change how we talk about and treat obesity. In Omada Health's latest whitepaper, we focus on the need to reframe obesity as a complex chronic condition that requires long-term, often lifelong treatment. This is especially true in the age of GLP-1s. Read the full whitepaper here: https://lnkd.in/e34kCZt9